• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

Breast Cancer

AWS, PHDA Collaborate to Develop Breast Cancer Screening and Depression Machine Learning Models

by Fred Pennic 10/06/2020 Leave a Comment

AWS, PHDA Collaborate to Develop Breast Cancer Screening and Depression Machine Learning Models

What You Should Know: - Amazon Web Services (AWS) and the Pittsburgh Health Data Alliance (PHDA) announce a collaboration to produce more accurate machine learning models for breast cancer screening and depression. - In work funded through the PHDA-AWS collaboration, a research team led by Shandong Wu, an associate professor at the University of Pittsburgh Department of Radiology, is using deep-learning systems to analyze mammograms in order to predict the short‐term risk of developing
Read More

Consumer Genetic Tests Accelerate Precision Medicine for Some Providers

by Joel Diamond, MD, FAAFP, Chief Medical Officer at 2bPrecise 06/09/2020 Leave a Comment

Consumer Genetic Tests Accelerate Precision Medicine for Some Providers

Direct-to-consumer (DTC) genetic tests have been on the scene for some time now. The Federal Drug Administration (FDA) approved the first DTC test on three specific BRCA1/BRCA2 breast cancer gene mutations more than two years ago. Six months after that, the agency similarly green-lighted a DTC pharmacogenomic (PGx) test to examine 33 variants for eight different genes that indicate how effectively patients metabolize specific medications. Like many such advances, availability of DTC tests is
Read More

How AR and MR Technology Can Reduce Medical Vulnerability to Improve the Patient Experience

by Paul Jensen, President, Novarad 04/28/2020 Leave a Comment

How AR/MR Technology Can Reduce Medical Vulnerability for a Better Patient Experience

Hospitals and health systems work hard every day to deliver patient-centered care. In fact, “the patient experience” is something now being measured, monitored and discussed throughout the healthcare continuum. Yet for most patients, moments of anxiety and medical vulnerability still abound, and the conversation rarely addresses this important fact. Patients awaiting an X-ray, magnetic resonance imaging (MRI) or computed tomography (CT) scan, for instance, maybe fearful of the results.
Read More

XRHealth Lands $7M to Expand Telehealth VR/AR Platform

by Jasmine Pennic 04/22/2020 Leave a Comment

XRHealth Launches First Virtual Reality TeleHealth Clinic

What You Should Know: XRHealth raises $7M in funding to expand its telehatlh virtual reality (VR)/augmented reality (AR) platform for clinicians and patients. XRHealth is the first certified Extended Reality medical company in the world; their Medical Applications are FDA & CE Registered.  XRHealth created the first virtual reality telehealth clinic in the world that is currently certified in 17 states.  XRHealth, formerly known as VRHealth a provider of extended
Read More

COVID-19: XRHealth Launches Virtual Reality Telehealth Supports Groups

by Jasmine Pennic 03/16/2020 Leave a Comment

XRHealth Launches First Virtual Reality TeleHealth Clinic

What You Need to Know: - In response to the growing social distancing precautions to avoid the spread of COVID-19, XRHealth is making VR telehealth support groups available for patients. - XRHealth support groups are tailored for patients with the following conditions: Multiple Sclerosis, Parkinson's, breast cancer, menopause, an injury that affected motor function, anxiety, chronic pain, fibromyalgia, substance abuse, post-stroke rehabilitation, brain injury and there will also be a
Read More

LifeOmic, Susan G. Komen Tissue Bank Partner to Advance Breast Cancer Research

by Jasmine Pennic 01/23/2020 Leave a Comment

LifeOmic, Susan G. Komen Tissue Bank Partner to Advance Breast Cancer Research

- Susan G. Komen Tissue Bank partners with LifeOmic to aggregate and analyze data on LifeOmic’s AI-powered cloud platform, the Precision Health Cloud (PHC), to gain insight into breast cancer. - The Komen Tissue Bank is the only repository in the world for normal breast tissue and matched serum, plasma, and DNA. The tissue bank advances breast cancer research by offering high quality, richly annotated tissue samples to scientists worldwide. LifeOmic, the creator of the LIFE mobile apps and the
Read More

UChicago Medicine Selects Life Image’s Breast Health Data Tool

by Jasmine Pennic 01/20/2020 Leave a Comment

UChicago Medicine Selects Life Image’s Breast Health Data Tool

- UChicago Medicine working with Mammosphere by Life Image to allow patients easy, secure access to their breast imaging and to support the WISDOM Study to establish screening guidelines. - Mammosphere was developed to support women throughout their entire breast health journey, including contributing to scientific research. By offering patients this digital tool, patients in the WISDOM Study will have additional tools to support their long-term commitment to the research.Life Image, the world’s
Read More

3 AI Trends for 2020: Moving Beyond Dazzle to High-Impact Collaboration

by Jordan Bazinsky, EVP and Administrative Officer for Cotiviti 01/03/2020 Leave a Comment

3 AI Trends for 2020: Moving Beyond Dazzle to High-Impact Collaboration

From the first artificial skin to driverless cars that navigate busy streets with ease, 2019 brought a dazzling array of artificial intelligence (AI) discovery. In 2020, the progress made toward AI-fueled collaboration will be as critical as AI innovation—especially in healthcare. We’ve reached a point where AI has proven its utility. In radiology, for example, AI is well-oriented to interpret diagnostic imaging studies, with FDA approval given to AI algorithms that diagnose a collapsed lung or
Read More

Thinking Pink: The Case for Femtech in 2020 & Beyond

by Judith Nowlin, Chief Growth Officer for Babyscripts 01/02/2020 Leave a Comment

Thinking Pink: The Case for Femtech

If health systems are going to retain and attract new customers, femtech is a critical starting place: it’s what women want. In 2012, investments in female-specific health technology (femtech, as it has been coined) totaled $57M. By the close of 2019, they’re projected to reach $1B. That’s a 1651% increase in a mere seven years — and the numbers continue to climb.  The boom can be pinned to a multitude of causes, not least among them a growing (though still very much in the minority) number of
Read More

5 Ways Artificial Intelligence Is Transforming Digital Pathology

by HITC Staff 11/22/2019 Leave a Comment

Clinical Operations Makes Highest Use of Artificial Intelligence, Tufts Study Finds

- As the digital pathology market grows, facilities that rely on digital pathology will start using artificial intelligence (AI) to assist. AI could help health professionals cope with the gigantic quantities of data - Discover why healthcare facilities increasingly realize that AI could help achieve significant impacts with digital pathology.Thanks to approvals from the Food and Drug Administration (FDA) for applications such as primary disease diagnosis, digital pathology is rapidly becoming
Read More

  • Previous Page
  • Go to page 1
  • Interim pages omitted …
  • Go to page 4
  • Go to page 5
  • Go to page 6
  • Go to page 7
  • Go to page 8
  • Next Page

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Paradigm Shift in Diabetes Care with Studio Clinics: Q&A with Reach7 Founder Chun Yong

Most-Read

Medtronic to Separate Diabetes Business into New Standalone Company

Medtronic to Separate Diabetes Business into New Standalone Company

White House, IBM Partner to Fight COVID-19 Using Supercomputers

HHS Sets Pricing Targets for Trump’s EO on Most-Favored-Nation Drug Pricing

23andMe to Mine Genetic Data for Drug Discovery

Regeneron to Acquire Key 23andMe Assets for $256M, Pledges Continuity of Consumer Genome Services

CureIS Healthcare Sues Epic: Alleges Anti-Competitive Practices & Trade Secret Theft

The Evolving Role of Physician Advisors: Bridging the Gap Between Clinicians and Administrators

The Evolving Physician Advisor: From UM to Value-Based Care & AI

UnitedHealth Group Names Stephen Hemsley CEO as Andrew Witty Steps Down

UnitedHealth CEO Andrew Witty Steps Down, Stephen Hemsley Returns as CEO

Omada Health Files for IPO

Omada Health Files for IPO

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

2019 MedTech Breakthrough Award Category Winners Announced

MedTech Breakthrough Announces 2025 MedTech Breakthrough Award Winners

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |